TNF-α blockade with etanercept for successful therapy of refractory acute and chronic graft-versus-host disease.

被引：0
|
作者：
Oyama, Y [1 ]
Ali, Y [1 ]
Tallman, M [1 ]
Winter, J [1 ]
Falco, A [1 ]
O'Connor, N [1 ]
Fishman, MA [1 ]
Welles, C [1 ]
Williams, S [1 ]
Singhal, S [1 ]
Gordon, L [1 ]
Mehta, J [1 ]
机构：
[1] Northwestern Univ, Sch Med, Chicago, IL USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5214
引用
收藏
页码：360B / 360B
页数：1
相关论文
共 50 条
  • [1] Treatment with etanercept for corticosteroid refractory acute graft-versus-host disease. A single centre experience
    Torrent, Anna
    Jose Jimenez-Lorenzo, Maria
    Ferra, Christelle
    Morgades, Mireia
    Vives, Susana
    Moreno, Miriam
    Batlle, Montserrat
    Xicoy, Blanca
    Manuel Sancho, Juan
    Abril, Laura
    Ibarra, Gladys
    Oriol, Albert
    Pena, Marta
    Sitges, Marta
    Maria Ribera, Josep
    BONE MARROW TRANSPLANTATION, 2019, 54 : 335 - 335
  • [2] Infliximab as treatment for steroid refractory acute and chronic graft-versus-host disease.
    Trenschel, R
    Ditschkowski, M
    Biersack, H
    Trampenau, C
    Steckel, NK
    Peceny, R
    Ottinger, H
    Elmaagacli, A
    Scheulen, ME
    Beelen, DW
    Schaefer, UW
    BLOOD, 2002, 100 (11) : 450B - 450B
  • [3] Etanercept as salvage therapy for chronic graft-versus-host disease
    Gulbis, A. M.
    Hsu, Y.
    Neumann, J. L.
    Hymes, S.
    de Lima, M. J.
    Hosing, C. M.
    Khouri, I. F.
    Qazilbash, M. H.
    Kebriaei, P.
    Andersson, B. S.
    Champlin, R. E.
    Couriel, D. P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 107 - 108
  • [4] Response to thalidomide therapy in patients with refractory chronic graft-versus-host disease.
    Browne, PV
    Wagner, J
    Weisdorf, DJ
    DeFor, T
    Miller, WJ
    Davies, SM
    Filipovich, A
    McGlave, PB
    Ramsay, NKC
    Enright, H
    BLOOD, 1995, 86 (10) : 1577 - 1577
  • [5] Thalidomide for acute or chronic graft-versus-host disease.
    Kulkarni, S
    Powles, R
    Mehta, J
    Horton, C
    Treleaven, J
    Middleton, G
    Eisen, T
    Singhal, S
    BLOOD, 1996, 88 (10) : 2424 - 2424
  • [6] Alemtuzumab in the treatment of steroid refractory acute Graft-versus-Host Disease.
    Gomez-Almaguer, David
    Ruiz-Arguelles, Guillermo
    Gonzalez-Llano, Oscar
    Cantu, Olga G.
    Gutierrez, Cesar H.
    Jaime-Perez, Jose Carlos
    Tarin-Arzaga, Luz
    Giralt, Sergio
    BLOOD, 2006, 108 (11) : 415B - 416B
  • [7] COMBINATION THERAPY WITH INOLIMOMAB AND ETANERCEPT FOR SEVERE STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE
    Van Groningen, L.
    Liefferink, A.
    de Haan, A.
    Schaap, N.
    Donnelly, P.
    Blijlevens, N.
    van der Velden, W.
    HAEMATOLOGICA, 2015, 100 : 279 - 279
  • [8] Combination Therapy with Inolimomab and Etanercept for Severe Steroid-Refractory Acute Graft-versus-Host Disease
    van Groningen, Lenneke F. J.
    Liefferink, Aleida M.
    de Haan, Anton F. J.
    Schaap, Nicolaas P. M.
    Donnelly, J. Peter
    Blijlevens, Nicole M. A.
    van der Velden, Walter J. F. M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (01) : 179 - 182
  • [9] Salvage therapy with basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease
    Freyer, Craig W.
    Gier, Shannon
    Carulli, Alison
    Gill, Saar I.
    Hexner, Elizabeth O.
    Loren, Alison W.
    Martin, Mary Ellen
    Porter, David L.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (07) : E273 - E276
  • [10] Etanercept treatment for steroid refractory acute graft-versus-host disease (GVHD) of the intestine
    Detrait, M.
    Van denneste, E.
    Vekemans, M. C.
    Sone, A.
    Bosly, A.
    Lambert, C.
    Hermans, C.
    Ferrant, A.
    ACTA CLINICA BELGICA, 2007, 62 (04): : 267 - 267
12345